Core Laboratories Nv Stock Story
| CLB Stock | USD 16.53 0.46 2.71% |
About 63% of Core Laboratories' investor base is looking to short. The analysis of overall sentiment of trading Core Laboratories NV stock suggests that many investors are alarmed at this time. Core Laboratories' investor sentiment overview provides quick insight into current market opportunities from investing in Core Laboratories NV. The current market sentiment, together with Core Laboratories' historical and current headlines, can help investors time the market. In addition, many technical investors use Core Laboratories stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Core Laboratories stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Core daily returns and investor perception about the current price of Core Laboratories NV as well as its diversification or hedging effects on your existing portfolios.
Core |
Requested story not found. it has been either deleted or moved. View all stories for Core Laboratories NV.
Core Laboratories Latest Timeline
Core Laboratories is traded for 16.53. About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Core Laboratories was currently reported as 4.8. The company has Price/Earnings To Growth (PEG) ratio of 2.15. Core Laboratories last dividend was issued on the 9th of February 2024. The entity had 2:1 split on the 9th of July 2010.Check out Core Laboratories Hype Analysis, Core Laboratories Correlation and Core Laboratories Performance. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Core Stock analysis
When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.72) | Dividend Share 0.04 | Earnings Share 0.51 | Revenue Per Share 10.92 | Quarterly Revenue Growth 0.005 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.